Munafa Stock Market Course + Intraday & FNO calls 
Glaxosmithkline Plc (GSK) Technical (Analysis) Reports Glaxosmithkline Plc ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Glaxosmithkline Plc (GSK)
Technical Analysis Report for USA stock GSK Glaxosmithkline Plc. Dated: 23 Mar 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in USA stock exchange
If you are looking for Tomorrow's Movement Predictions for USA stock GSK Glaxosmithkline Plc then click here. or read Experts views on Glaxosmithkline Plc or Forecast & share price targets of Glaxosmithkline Plc
Glaxosmithkline Plc Opened at 52.19 and Closed at: 51.99, which is 0.31% of previous session's close. It moved within a range of 51.80 and 52.69
The session was a Bearish session with an average volume of 4333600, which is 28.55% of previous session's volumes.
- Even though the stock has shown an up move, but the short term trend of the stock remains negative and in a downtrend.
- The stock has shown an up move, and its mid term trend is also positive and in an uptrend.
- The stock has shown an up move, and its long term trend is also positive and in an uptrend.
A Dead cross was found 3 days back on mid term averages
Support for tomorrow is 51.45 and resistance for tomorrow is 52.34
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 51.63, 51.27 resistance for tomorrow's hourly charts is 52.52, 53.05
10 Day SMA for Glaxosmithkline Plc (GSK) is 53.7 and stock is trading below these levels. This is not a good sign for its short term trend
20 Day SMA for Glaxosmithkline Plc (GSK) is 55.71 and the stock is trading below these levels. This is not a good sign for its mid term trend
50 Day SMA for Glaxosmithkline Plc (GSK) is 54.75 and the stock is trading below these levels. This is not a good sign for its mid to long term trend
100 Day SMA is 51.39 and the stock is trading above these levels. This is a good sign for its long term trend
200 Day SMA Glaxosmithkline Plc is 45.73 and stock is trading above these levels. This is a good sign for its long term trend
20 DMA of Glaxosmithkline Plc is at 55.71 and 200 DMA is at 45.73, while 50 DMA and 100 DMA are at 54.75 and 51.39 respectively
Glaxosmithkline Plc (GSK) moving average of 20 SMA is at 55.71 and 20 EMA is at 54.77
| Date | Closing Price | 20 SMA | 20 EMA |
| 23 Mon Mar | 51.99 | 55.71 | 54.77 |
| 20 Fri Mar | 51.83 | 56.08 | 55.06 |
| 19 Thu Mar | 52.39 | 56.53 | 55.4 |
| 17 Tue Mar | 53.41 | 56.97 | 55.72 |
| 16 Mon Mar | 53.77 | 57.35 | 55.96 |
| 13 Fri Mar | 53.39 | 57.6 | 56.19 |
Glaxosmithkline Plc (GSK) moving average of 50 SMA is at 54.75 and 50 EMA is at 54.29
| Date | Closing Price | 50 SMA | 50 EMA |
| 23 Mon Mar | 51.99 | 54.75 | 54.29 |
| 20 Fri Mar | 51.83 | 54.72 | 54.38 |
| 19 Thu Mar | 52.39 | 54.69 | 54.48 |
| 17 Tue Mar | 53.41 | 54.65 | 54.57 |
| 16 Mon Mar | 53.77 | 54.57 | 54.62 |
| 13 Fri Mar | 53.39 | 54.48 | 54.65 |
Glaxosmithkline Plc (GSK) moving average of 100 SMA is at 51.39 and 100 EMA is at 51.61
| Date | Closing Price | 100 SMA | 100 EMA |
| 23 Mon Mar | 51.99 | 51.39 | 51.61 |
| 20 Fri Mar | 51.83 | 51.31 | 51.6 |
| 19 Thu Mar | 52.39 | 51.22 | 51.6 |
| 17 Tue Mar | 53.41 | 51.17 | 51.58 |
| 16 Mon Mar | 53.77 | 51.07 | 51.54 |
| 13 Fri Mar | 53.39 | 50.98 | 51.49 |
Glaxosmithkline Plc (GSK) moving average of 200 SMA is at 45.73 and 200 EMA is at 47.67
| Date | Closing Price | 200 SMA | 200 EMA |
| 23 Mon Mar | 51.99 | 45.73 | 47.67 |
| 20 Fri Mar | 51.83 | 45.67 | 47.63 |
| 19 Thu Mar | 52.39 | 45.61 | 47.59 |
| 17 Tue Mar | 53.41 | 45.54 | 47.54 |
| 16 Mon Mar | 53.77 | 45.47 | 47.48 |
| 13 Fri Mar | 53.39 | 45.4 | 47.42 |
Takeda Pharmaceutical has performed better than Glaxosmithkline Plc in short term. You could have earned much better returns by investing in Takeda Pharmaceutical, about 7.27% more returns!
Dr Reddy has performed better than Glaxosmithkline Plc in short term. You could have earned much better returns by investing in Dr Reddy, about 5.4% more returns!
Penumbra Inc has performed better than Glaxosmithkline Plc in short term. You could have earned much better returns by investing in Penumbra Inc, about 11.2% more returns!
Hca Healthcare has performed better than Glaxosmithkline Plc in short term. You could have earned much better returns by investing in Hca Healthcare, about 4.55% more returns!
Boston Scientific has performed better than Glaxosmithkline Plc in short term. You could have earned much better returns by investing in Boston Scientific, about 5.78% more returns!
Glaxosmithkline Plc has performed better than Bausch Health in short term. Holding Glaxosmithkline Plc could be a better choice for now!
Staar Surgical has performed better than Glaxosmithkline Plc in short term. You could have earned much better returns by investing in Staar Surgical, about 16.49% more returns!
Sellas Life has performed better than Glaxosmithkline Plc in short term. You could have earned much better returns by investing in Sellas Life, about 44.32% more returns!
Prothena Corporation has performed better than Glaxosmithkline Plc in short term. You could have earned much better returns by investing in Prothena Corporation, about 10.05% more returns!
Pavmed Inc has performed better than Glaxosmithkline Plc in short term. You could have earned much better returns by investing in Pavmed Inc, about 16.07% more returns!
Glaxosmithkline Plc has performed better than Ionis Pharmaceuticals in short term. Holding Glaxosmithkline Plc could be a better choice for now!
Incyte Corporation has performed better than Glaxosmithkline Plc in short term. You could have earned much better returns by investing in Incyte Corporation, about 1.54% more returns!
Henry Schein has performed better than Glaxosmithkline Plc in short term. You could have earned much better returns by investing in Henry Schein, about 5.85% more returns!
Exelixis Inc has performed better than Glaxosmithkline Plc in short term. You could have earned much better returns by investing in Exelixis Inc, about 7.18% more returns!
Celldex Therapeutics has performed better than Glaxosmithkline Plc in short term. You could have earned much better returns by investing in Celldex Therapeutics, about 50.41% more returns!
Axogen Inc has performed better than Glaxosmithkline Plc in short term. You could have earned much better returns by investing in Axogen Inc, about 2.21% more returns!
Glaxosmithkline Plc has performed better than Apellis Pharmaceuticals in short term. Holding Glaxosmithkline Plc could be a better choice for now!
Amgen Inc has performed better than Glaxosmithkline Plc in short term. You could have earned much better returns by investing in Amgen Inc, about 5.6% more returns!
Glaxosmithkline Plc Technical analysis of indicators
Price action analysis of Glaxosmithkline Plc (GSK) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Glaxosmithkline Plc stock for short term is SELL. Signal strength is Strong and stock is losing momentum.
MACD generated a SELL signal for Glaxosmithkline Plc in short term and the sell signal is strong.
Glaxosmithkline Plc Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up
CCI has generated a buy signal for Glaxosmithkline Plc in short term but BUY signal is weak.
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Glaxosmithkline Plc is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 53.86 and Glaxosmithkline Plc GSK stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Glaxosmithkline Plc GSK stock. Volume based technical analysis of Glaxosmithkline Plc GSK stock is negative.
Glaxosmithkline Plc Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for USA stock GSK Glaxosmithkline Plc These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And GSK Experts View which covers a lot of information including buying and selling signals
GSK future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Glaxosmithkline Plc or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Glaxosmithkline Plc (GSK) Technical (Analysis) Reports Glaxosmithkline Plc ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Hindi Video Correct Way Of Technical Analysis How To Find Entry Exit Points On Charts
Hindi Video Most Important Stock Market Video. No Success Without This Formula
- USA Screeners
- USA Daily Screener
- USA Weekly Screener
- USA Monthly Screener
- Support & Resistance
- USA Shares Near Support
- USA Shares Near Resistance
